These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19284605)

  • 1. Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartments.
    Fuchs D; Christofferson R; Stridsberg M; Lindhagen E; Azarbayjani F
    J Transl Med; 2009 Mar; 7():16. PubMed ID: 19284605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHS 828 inhibits neuroblastoma growth in mice alone and in combination with antiangiogenic drugs.
    Svensson A; Bäckman U; Jonsson E; Larsson R; Christofferson R
    Pediatr Res; 2002 May; 51(5):607-11. PubMed ID: 11978885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metronomic administration of the drug GMX1777, a cellular NAD synthesis inhibitor, results in neuroblastoma regression and vessel maturation without inducing drug resistance.
    Fuchs D; Rodriguez A; Eriksson S; Christofferson R; Sundberg C; Azarbayjani F
    Int J Cancer; 2010 Jun; 126(12):2773-89. PubMed ID: 20112275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.
    Pastorino F; Brignole C; Di Paolo D; Nico B; Pezzolo A; Marimpietri D; Pagnan G; Piccardi F; Cilli M; Longhi R; Ribatti D; Corti A; Allen TM; Ponzoni M
    Cancer Res; 2006 Oct; 66(20):10073-82. PubMed ID: 17047071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.
    Joseph JM; Gross N; Lassau N; Rouffiac V; Opolon P; Laudani L; Auderset K; Geay JF; Mühlethaler-Mottet A; Vassal G
    Int J Cancer; 2005 Mar; 113(6):881-90. PubMed ID: 15514941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and characterization of new orthotopic and metastatic neuroblastoma models.
    Daudigeos-Dubus E; LE Dret L; Rouffiac V; Bawa O; Leguerney I; Opolon P; Vassal G; Geoerger B
    In Vivo; 2014; 28(4):425-34. PubMed ID: 24982206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis can be reduced without significant reduction of tumor growth.
    Svensson A; Bäckman U; Fuchs D; Christofferson R; Azarbayjani F
    Anticancer Res; 2007; 27(6B):3883-9. PubMed ID: 18225546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
    Yang Q; Tian Y; Liu S; Zeine R; Chlenski A; Salwen HR; Henkin J; Cohn SL
    Cancer Res; 2007 Feb; 67(4):1716-24. PubMed ID: 17308113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in mice.
    Huang CC; Wang SY; Lin LL; Wang PW; Chen TY; Hsu WM; Lin TK; Liou CW; Chuang JH
    Dis Model Mech; 2015 Oct; 8(10):1247-54. PubMed ID: 26398947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adeno-associated virus vector-mediated systemic delivery of IFN-beta combined with low-dose cyclophosphamide affects tumor regression in murine neuroblastoma models.
    Streck CJ; Dickson PV; Ng CY; Zhou J; Gray JT; Nathwani AC; Davidoff AM
    Clin Cancer Res; 2005 Aug; 11(16):6020-9. PubMed ID: 16115947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis.
    Bäckman U; Svensson A; Christofferson RH; Azarbayjani F
    Anticancer Res; 2008; 28(3A):1551-7. PubMed ID: 18630510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin-mediated concomitant resistance in neuroblastoma.
    Streck C; Zhang Y; Zhou J; Ng CY; Davidoff A
    J Pediatr Surg; 2004 Mar; 39(3):405-11; discussion 405-11. PubMed ID: 15017561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenografts.
    Rössler J; Monnet Y; Farace F; Opolon P; Daudigeos-Dubus E; Bourredjem A; Vassal G; Geoerger B
    Int J Cancer; 2011 Jun; 128(11):2748-58. PubMed ID: 20715103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Simple and Reproducible Cell-derived Orthotopic Xenograft Murine Model for Neuroblastoma.
    Doyle K; Hassan AE; Sutter M; Rodriguez M; Kumar P; Brown E
    In Vivo; 2024; 38(2):531-538. PubMed ID: 38418146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic therapy inhibits human neuroblastoma growth.
    Katzenstein HM; Salwen HR; Nguyen NN; Meitar D; Cohn SL
    Med Pediatr Oncol; 2001 Jan; 36(1):190-3. PubMed ID: 11464880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR‑410 in human neuroblastoma cells.
    Boyineni J; Tanpure S; Gnanamony M; Antony R; Fernández KS; Lin J; Pinson D; Gondi CS
    Int J Oncol; 2016 Oct; 49(4):1394-406. PubMed ID: 27498840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    Pastorino F; Brignole C; Marimpietri D; Cilli M; Gambini C; Ribatti D; Longhi R; Allen TM; Corti A; Ponzoni M
    Cancer Res; 2003 Nov; 63(21):7400-9. PubMed ID: 14612539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
    Bäckman U; Christofferson R
    Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction of neuroblastoma angiogenesis and growth by interferon-alpha/beta.
    Streck CJ; Zhang Y; Miyamoto R; Zhou J; Ng CY; Nathwani AC; Davidoff AM
    Surgery; 2004 Aug; 136(2):183-9. PubMed ID: 15300178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.